Achiko Logo cropped.jpg
AptameX Production and Commercialization Update
28 avr. 2022 08h15 HE | Achiko AG
Company has commenced shipping and will book first sales in May 2022Reorganized production line able to meet stronger than expected demand for Achiko AG’s innovative DNA aptamer saliva-based rapid...
Achiko Logo cropped.jpg
Achiko AG Research Paper and Commercialization Update
14 févr. 2022 07h30 HE | Achiko AG
Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as “DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for...
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
06 janv. 2022 07h00 HE | First Wave BioPharma, Inc.
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral Formulation of Niclosamide, and Expand Safety Observations on...
Achiko Logo cropped.jpg
Achiko AG Completing CHF4.85m Financing and Changes to Senior Team
31 déc. 2021 07h30 HE | Achiko AG
Completing CHF 4.85 Million Placement from August 2021Board Director Christophe Laurent to RetireAppoints Adam O’Keeffe as Ad Interim Chief Financial Officer ZURICH, Switzerland, Dec. 31, 2021 ...
Achiko Logo cropped.jpg
Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COVID-19 Testing Solution
23 déc. 2021 07h30 HE | Achiko AG
2021 Was a Pivotal Year for Achiko, Marked by Seminal Developments and ApprovalsWith AptameX™, Achiko Launched an Innovative DNA Aptamer Saliva-Based Rapid Test for Covid-19 as an Affordable and...
AptameX™ :  Achiko’s DNA Aptamer-Based Covid-19 Rapid Test
Achiko AG’s Shares Begin Trading on the OTCQB Market
20 déc. 2021 07h30 HE | Achiko AG
ZURICH, Switzerland, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468; (“Achiko”, the “Company”), a global healthtech company which has...
First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board
09 déc. 2021 07h00 HE | First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Codex DNA Releases F
Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
01 sept. 2021 16h15 HE | Codex
San Diego, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of its first full-length...
BioStem Technologies Main Logo.jpg
BioStem Technologies Reports Record Breaking Second Quarter Sales
25 août 2021 11h15 HE | BioStem Technologies, Inc.
Company on Pace to Exceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life...
Physicians Offer Texas Governor Abbott Early COVID-19 Treatment
20 août 2021 09h42 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Upon learning of Gov. Greg Abbott’s COVID-19 diagnosis, the Association of American Physicians and Surgeons (AAPS) and its Texas chapter sent the...